본문 바로가기
KERD
논문KCI 등재

침습성 아스페르길루스증 진단을 위한 Platelia Aspergillus 항원 검사법의 평가

The Evaluation of Clinical Utility of Platelia Aspergillus AntigenImmunoassay for Diagnosis of Invasive Aspergillosis

2

조회

0

다운로드

1

인용

0

참고문헌

초록

배경:침습성 아스페르길루스증(invasive aspergillosis, IA)은 치명율이 50%가 넘기 때문에 조기 진단과 적절한 치료가 예후에 결정적인 영향을 준다. 최근 Aspergillus galactomannan 항원(AG) 검사가 IA를 진단하고 모니터링하는 방법으로 인정받고 있어서, IA 진단을 위해 AG 검사를 도입하고 그 유용성을 평가하고자 하였다. 방법:2004년 9월부터 2005년 5월까지 AG 검사를 의뢰한 149명의 175검체를 대상으로 후향적으로평가하였다. IA의 정의는 European Organization for Research and Treatment of Cancer/Mycoses Study Group(EORTC/MSG)의 진단기준을 적용해서 ‘증명된’, ‘거의 확실한’, ‘가능성 있는’IA로 구분하였다. AG는 Platelia Aspergillus (Bio-Rad, Hercules, CA, USA) 항원 면역검사법으로 검사하였으며, 두 개의 cut-off 대조군의 평균으로 나눈 cut-off 비가 1.5 이상은 양성, 1.0-1.5는 불확실로 해석하였다. 검사를 의뢰한 환자들의 항진균제, 항균제 투여력 등의 전산의무기록을 검토하였다. 결과:175검체 중 양성은 19검체 (10.9%), 불확실은 14검체 (8.0%), 음성은 142검체 (81.1%)였다. 환자의 병력을 검토한 결과 ‘증명된’, ‘거의 확실한’, ‘가능성 있는’IA 환자는 각각 2명 (1.3%), 15명 (10.1%), 28명 (18.8%)이었다. 위음성인 5명 중 항원 검사 전에 항진균제 치료를 받은 4명을 제외하면 검사의 예민도, 특이도, 양성예측도 및 음성예측도는 cut-off 비 1.5일 때 각각 76.9%, 94.7%, 58.8% 및 97.7%였다. 결론:Platelia Aspergillus 항원 면역검사법은 IA 진단을 위한 예민도, 특이도 및 음성예측도가 우수하였다. IA 진단을 위해 미생물학적 검사, 임상 평가 등과 함께 혈청 Aspergillus 항원을 측정하면 IA 진단에 유용할 것으로 판단하였다.

Abstract

Background: Because the mortality rate of invasive aspergillosis (IA) is more than 50%, an early diagnosis and appropriate management are important to achieve a favorable outcome. Aspergillus galactomannan (AG) antigen test has recently been introduced for diagnosis and monitoring of IA. This study was to evaluate the clinical utility of AG detection in diagnosis of IA. Methods:One hundred and seventy-five samples from 149 patients were tested for AG during the period from September 2004 to May 2005 and the results were evaluated retrospectively. IA was diagnosed into ‘proven’, ‘probable’and ‘possible’, groups based on patients’clinical laboratory findings as per European Organization for Research and Treatment of Cancer/Mycoses Study Group. AG was tested using a Platelia Aspergillus antigen ELISA (Bio-Rad, Hercules, CA, USA); the optical density (OD) of the test specimen was divided by the mean OD of two cut-off controls. The test was classified as positive when the OD ratio was ≥1.5; ratios 1-1.5 were classified as equivocal. Clinical Information was obtained from the electronic medical records of the patients. Results: Of the 175 samples tested, 19 were positive, 14 equivocal, and 142 negative for AG. A number of the ‘proven’, ‘probable’, and ‘possible’IA patients were 2, 15, and 28, respectively. At the OD ratio of 1.5, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 76.9%, 94.7%, 58.8%, and 97.7%, respectively, when 4 false-negative patients treated with amphotericin B before Aspergillusantigen test were excluded. Conclusion: The Platelia Aspergillus ELISA demonstrated an excellent sensitivity, specificity and NPV for the diagnosis of IA. A combined use of the antigen test with microbiological and clinical evaluation might facilitate the early diagnosis of IA and, consequently, improve its clinical outcome.

참고문헌 (26)

  1. "Rapid diagnosis of invasive aspergillosis by antigen detection", 5, pp.158~66 (2003)
  2. "Aspergillosis case-fatality rate:systematic review of the literature", 32, pp.358~66 (2001)
  3. "The changing face of invasive aspergillosis in liver transplant recipients", 8, pp.1071~2 (2002)
  4. "T^Denning D^Infect Dis Clin North", pp.875~94 (2002)
  5. "Aspergillusinfections after lung transplantation:clinical differences in type of transplant and implications for management", 22, pp.258~66 (2003)
  6. "British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections", 3, pp.230~40 (2003)
  7. "The radiologic spectrum of pulmonary Aspergillus infections", 26, pp.159~73 (2002)
  8. "Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients", 186, pp.1297~306 (2002)
  9. "Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis", 24, pp.1195~9 (1999), Bone Marrow Transplant
  10. "A new sensitives andwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis", 33, pp.497~500 (1995)
  11. "Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis", 37, pp.3223~8 (1999)
  12. "Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus", 34, pp.7~14 (2002)
  13. "Detection of circulating Aspergillus fumigatusgalactomannan:value and limits of the Platelia test for diagnosing invasive aspergillosis", 41, pp.2184~6 (2003)
  14. "Comparison of real-time PCR,conventional PCR,and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis", 41, pp.3922~5 (2003)
  15. "Prospective assessment of Platelia Aspergillus galactomannan antigen for the diagnosis of invasive aspergillosis in lung transplant recipients", 4, pp.796~802 (2004)
  16. "Adverse effects of corticosteroid therapy for COPD", 111, pp.732~43 (1997)
  17. "Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease:an emerging fungal pathogen", 11, pp.427~9 (2005)
  18. "Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon", 76, pp.1755~64 (1985)
  19. "Inhibition of monocyte-mediated damage to fungal hyphae by steroid hormones", 147, pp.160~ (1983)
  20. "Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment:etiology,prognostic factors,and associated inflammatory response", 123, pp.488~98 (2003)
  21. "Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits:the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection", 169, pp.356~68 (1994)
  22. "Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis", 4, pp.349~57 (2004)
  23. "Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay", 40, pp.1762~9 (2005)
  24. "False-positive galactomannan platelia Aspergillustest results for patients receiving piperacillin-tazobactam", 38, pp.913~6 (2004)
  25. "Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam:clinical implications based on achievable concentrations in serum", 48, pp.1989~92 (2004)
  26. "A case of expanding pulmonary aspergilloma", 35, pp.1430~3 (1997)

관련 논문AI추천

침습성 아스페르길루스증 진단을 위한 갈락토만난 항원 검사의 유용성 평가박경운, 박상원, 박완범, 송경호, 오명돈, 이신원, 장희창, 전재현, 최강원대한감염학회 · Infection and Chemotherapy2009 · 제41권 제2호Serum galactomannan levels in the diagnosis of invasive aspergillosisBeyza Ener, Esra Kazak, Fahir Ozkalemkas, Halis Akalin, Hasan Atilla Ozkan, Meral Gunaldi, Ridvan Ali, Sibel Ocak Serin, Tulay Ozcelik, Vildan Ozkocaman, Yildiz Okuturlar대한내과학회 · The Korean Journal of Internal Medicine2015 · 제30권 제6호침습성 진균 감염증의 새로운 진단법인 석탄산 산화효소 전구체 시스템을 이용한 (1→3)-β-D-glucan 농도 측정법의 유용성 평가 연구김남중, 김의석, 김홍빈, 박완범, 백정식, 어중혁, 오명돈, 윤종원, 이기덕, 이복률, 최강원대한감염학회 · Infection and Chemotherapy2006 · 제38권 제3호침습성 폐 아스페르길루스증의 역학과 임상상: 전국 다기관 연구권현희, 김성한, 김신우, 김양수, 문송미, 문수연, 배인규, 백경란, 이미숙, 정진원, 최영화, 추은주, 한상훈대한감염학회 · Infection and Chemotherapy2012 · 제44권 제4호Evaluation of Galactomannan Enzyme Immunoassay and Quantitative Real-Time PCR for the Diagnosis of Invasive Pulmonary Aspergillosis in a Rat ModelChang-ran Zhang, Jian-cong Lin, Ming Li, Pang Bo, Wen-ming Xu, Yan-li Xing, Yuan-yuan Niu한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2014 · 제24권 제8호국내 침습성 폐 아스페르길루스증의 역학 및 임상특징: 앞으로의 과제이동건대한감염학회 · Infection and Chemotherapy2012 · 제44권 제4호

이 간행물의 다른 논문 (15건)